Localization of CGRP receptor components and receptor binding sites in rhesus monkey brainstem: A detailed study using in situ hybridization, immunofluorescence, and autoradiography

No abstract is available for this paper.

• Publication year

  2016

• Venue

  The Journal of comparative neurology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/cne.23828PMID 26105175
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroanatomy

  2020cited by this paper
• Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier.

  2015influential reference
• Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks.

  2014cited by this paper
• Anti-CGRP antibodies for migraine turn industry heads

  2014cited by this paper
• BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial

  2014cited by this paper
• Hypothalamus as an endocrine organ.

  2014cited by this paper
• Pearls and pitfalls: Neuroimaging in headache

  2013cited by this paper
• Evaluation of c-Fos immunoreactivity in the rat brainstem nuclei relevant in migraine pathogenesis after electrical stimulation of the trigeminal ganglion

  2013cited by this paper
• Localization of CGRP Receptor Components, CGRP, and Receptor Binding Sites in Human and Rhesus Cerebellar Cortex

  2013influential reference
• Antibody drugs set to revive flagging migraine target

  2013cited by this paper
• The circumventricular organs of the brain: conspicuity on clinical 3T MRI and a review of functional anatomy

  2013cited by this paper
• Structural and Functional Neuroimaging in Migraine: Insights From 3 Decades of Research

  2013influential reference
• PET imaging in healthy subjects and migraineurs suggests CGRP receptor antagonists do not have to act centrally to achieve clinical efficacy

  2013cited by this paper
• In Vivo Quantification of Calcitonin Gene-Related Peptide Receptor Occupancy by Telcagepant in Rhesus Monkey and Human Brain Using the Positron Emission Tomography Tracer [11C]MK-4232

  2013cited by this paper
• Pain referral patterns of the C1 to C3 nerves: Implications for headache disorders

  2013cited by this paper
• Migraine: a brain state.

  2013cited by this paper
• [(11)C]MK-4232: The First Positron Emission Tomography Tracer for the Calcitonin Gene-Related Peptide Receptor.

  2013cited by this paper
• Migraine is not primarily a vascular disorder

  2012cited by this paper
• Mapping of CGRP in the alpaca diencephalon.

  2012cited by this paper
• Unraveling the contributions of the diencephalon to recognition memory: a review.

  2011cited by this paper
• Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine

  2011cited by this paper
• Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level

  2011influential reference
• BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study

  2011cited by this paper
• Trigeminal Nociceptive Transmission in Migraineurs Predicts Migraine Attacks

  2011influential reference
• Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat.

  2011cited by this paper
• Tracing neural connections to pain pathways with relevance to primary headaches

  2011cited by this paper
• The neurobiology of migraine.

  2010cited by this paper
• New drugs in migraine treatment and prophylaxis: telcagepant and topiramate.

  2010cited by this paper
• Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus.

  2010cited by this paper
• Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion.

  2010influential reference
• Pharmacological Properties of MK-3207, a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist

  2010influential reference
• A new trigemino-nociceptive stimulation model for event-related fMRI

  2010cited by this paper
• The hypothalamic median eminence and its role in reproductive aging

  2010cited by this paper
• Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus.

  2009cited by this paper
• Neurobiology of migraine.

  2009cited by this paper
• Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.

  2008cited by this paper
• Mapping of CGRP in the alpaca (Lama pacos) brainstem.

  2008cited by this paper
• Calcitonin receptor‐like receptor (CLR), receptor activity‐modifying protein 1 (RAMP1), and calcitonin gene‐related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: Differences between peripheral and central CGRP receptor distribution

  2008cited by this paper
• Recent advances in understanding migraine mechanisms, molecules and therapeutics.

  2007cited by this paper
• Peptidergic and Nitrergic Innervation of the Pineal Gland in the Domestic Pig: An Immunohistochemical Study

  2007cited by this paper
• The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide

  2007cited by this paper
• Sensitization of Calcitonin Gene-Related Peptide Receptors by Receptor Activity-Modifying Protein-1 in the Trigeminal Ganglion

  2007cited by this paper
• Salivary Levels of CGRP and VIP in Rhinosinusitis and Migraine Patients

  2006cited by this paper
• Localization of calcitonin receptor‐like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat

  2005cited by this paper
• Melatonin, the Pineal Gland and their Implications for Headache Disorders

  2005cited by this paper
• A positron emission tomographic study in spontaneous migraine.

  2005cited by this paper
• Vagus Nerve Stimulation Relieves Chronic Refractory Migraine and Cluster Headaches

  2005cited by this paper
• The role of CGRP and nicotinic receptors in centrally evoked facial blood flow changes.

  2005cited by this paper
• Calcitonin gene‐related peptide‐containing pathways in the rat forebrain

  2005cited by this paper
• Neurofilament proteins and cAMP pathway in brains of mu-, delta- or kappa-opioid receptor gene knock-out mice: effects of chronic morphine administration.

  2004cited by this paper
• Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

  2004cited by this paper
• The International Classification of Headache Disorders: 2nd edition.

  2004cited by this paper
• Herring bodies; an electron microscopic study of local degeneration and regeneration of neurosecretory axons

  2004cited by this paper
• Peripheral amylin activates circumventricular organs expressing calcitonin receptor a/b subtypes and receptor-activity modifying proteins in the rat.

  2004cited by this paper
• Peptidergic innervation in pars distalis of the human anterior pituitary.

  2004cited by this paper
• Neurofilament proteins and cAMP pathway in brains of μ-, δ- or κ-opioid receptor gene knock-out mice: effects of chronic morphine administration

  2004cited by this paper
• A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate.

  2004cited by this paper
• Headache: lessons learned from functional imaging.

  2003cited by this paper
• The International Classification of Headache Disorders: 2nd edition

  2003cited by this paper
• Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems.

  2003cited by this paper
• Melatonin: a significant contributor to the pathogenesis of migraine.

  2001cited by this paper
• Neuronal messengers in the human cerebral circulation.

  2001influential reference
• Hypothalamic involvement in chronic migraine

  2001cited by this paper
• Brainstem activation specific to migraine headache.

  2001cited by this paper
• Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain.

  2001cited by this paper
• Trigeminal Nociception-Induced Cerebral Fos Expression in the Conscious Rat

  2001influential reference
• Neuropeptide Localization in the ‘Migraine Generator’ Region of the Human Brainstem

  2001cited by this paper
• The periaqueductal grey matter modulates trigeminovascular input: a role in migraine?

  2001cited by this paper
• CGRP-RCP, a Novel Protein Required for Signal Transduction at Calcitonin Gene-related Peptide and Adrenomedullin Receptors*

  2000influential reference
• Pathophysiology of Migraine — New Insights

  1999cited by this paper
• Trigeminal innervation of the mammalian pineal gland

  1999cited by this paper
• The Rhesus Monkey Brain in Stereotaxic Coordinates

  1999cited by this paper
• Hypothalamic activation in cluster headache attacks.

  1998cited by this paper
• RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor

  1998cited by this paper
• Headache Secondary to Deep Brain Implantation

  1998influential reference
• Positron Emission Tomography Studies in Headache

  1997cited by this paper
• Detailed mapping of CGRP mRNA expression in the rat central nervous system: comparison with previous immunocytochemical findings.

  1995cited by this paper
• Brain stem activation in spontaneous human migraine attacks

  1995influential reference
• Distribution of messenger RNAs encoding enkephalin, substance P, somatostatin, galanin, vasoactive intestinal polypeptide, neuropeptide Y, and calcitonin gene‐related peptide in the midbrain periaqueductal grey in the rat

  1994cited by this paper
• The dorsal raphe: an important nucleus in pain modulation.

  1994cited by this paper
• Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues.

  1994influential reference
• The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats

  1993cited by this paper
• Calcitonin gene-related peptide: multiple actions, multiple receptors.

  1992cited by this paper
• Pineal melatonin: cell biology of its synthesis and of its physiological interactions.

  1991cited by this paper
• Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

  1990cited by this paper
• Calcitonin gene-related peptide (CGRP)-positive neurons and fibers in the cat periaqueductal grey matter.

  1989influential reference
• Nocturnal Plasma Melatonin Levels in Migraine: A Preliminary Report

  1989cited by this paper
• Innervation of the Cerebral Circulation a

  1987cited by this paper
• Headache May Arise From Perturbation of Brain

  1987cited by this paper
• Autoradiographic localization of calcitonin gene-related peptide binding sites in human and rat brains.

  1986cited by this paper
• Localization of binding sites for calcitonin gene-related peptide in rat brain by in vitro autoradiography.

  1986cited by this paper
• Quantitative distribution of calcitonin gene-related peptide in the rat central nervous system.

  1985cited by this paper
• Calcitonin gene-related peptide: detailed immunohistochemical distribution in the central nervous system.

  1985cited by this paper
• Hypothalamus as an endocrine organ--I.

  1974cited by this paper

• Unmasking the relationship between CGRP and glutamate: from peripheral excitation to central sensitization in migraine

  2025cites this paper
• Cerebrospinal Fluid Concentrations of Calcitonin Gene Related Peptide in Dogs With Chiari‐Like Malformation

  2025cites this paper
• Refractory Nausea and Vomiting Due to Central Nervous System Injury: A Focused Review

  2025cites this paper
• Expression of melatonin receptors in trigeminal and sphenopalatine ganglia: potential targets for primary headache disorders

  2025cites this paper
• Sex differences in PD‐L1‐induced analgesia in paclitaxel‐induced peripheral neuropathy mice depend on TRPV1‐based inhibition of CGRP

  2024cites this paper
• Pathophysiology of Migraine

  2024cites this paper
• CGRP receptor antagonists (gepants).

  2024cites this paper
• Double-blind, randomized, placebo-controlled study to evaluate erenumab-specific central effects: an fMRI study

  2024cites this paper
• Metabolic Dysfunction in Idiopathic Intracranial Hypertension: Current Theories and Updates

  2024cites this paper
• Molecular Mechanisms of Migraine: Nitric Oxide Synthase and Neuropeptides

  2023cites this paper
• Shared and independent roles of CGRP and PACAP in migraine pathophysiology

  2023cites this paper
• Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues

  2023cites this paper
• The anatomy of head pain.

  2023cites this paper
• Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA.

  2023cites this paper
• Calcitonin receptor antibody validation and expression in the rodent brain

  2022cites this paper
• CGRP-dependent sensitization of PKC-δ positive neurons in central amygdala mediates chronic migraine

  2022cites this paper
• Characterization of Antibodies against Receptor Activity-Modifying Protein 1 (RAMP1): A Cautionary Tale

  2022influential citation
• Role of PACAP in migraine: An alternative to CGRP?

  2022cites this paper
• CGRP physiology, pharmacology, and therapeutic targets: Migraine and beyond.

  2022cites this paper
• Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target – an fMRI study

  2022cites this paper
• Lipidated Calcitonin Gene-Related Peptide (CGRP) Peptide Antagonists Retain CGRP Receptor Activity and Attenuate CGRP Action In Vivo

  2022cites this paper
• Identifying New Antimigraine Targets: Lessons from Molecular Biology.

  2021cites this paper
• The CGRP Family of Neuropeptides and their Receptors in the Trigeminovascular System

  2021cites this paper
• Human Models

  2021cites this paper
• Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension

  2021cites this paper
• Biological and small molecule strategies in migraine therapy with relation to the calcitonin gene‐related peptide family of peptides

  2021cites this paper
• Experts and national consultants' recommendations regarding management of patients treated for migraine with comorbid depression. Epidemiology. Pathomechanism. Comorbidity. Part 1.

  2021cites this paper
• Update on Calcitonin Gene-Related Peptide Antagonism in the Treatment of Migraine.

  2021cites this paper
• Amylin deposition activates HIF1α and 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 (PFKFB3) signaling in failing hearts of non-human primates

  2021cites this paper
• CGRP: from history to clinical application - A review

  2020cites this paper
• Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators

  2020cites this paper
• Persistent Post-Traumatic Headache and Migraine: Pre-Clinical Comparisons

  2020cites this paper
• CGRP receptor antagonist MK-8825 attenuates cortical spreading depression induced pain behavior

  2019cites this paper
• Molecular studies of CGRP and the CGRP family of peptides in the central nervous system

  2019cites this paper
• CGRP – a target for acute therapy in migraine: Clinical data

  2019cites this paper
• Distribution of CGRP and CGRP receptor components in the rat brain

  2019cites this paper
• Recognizing the role of CGRP and CGRP receptors in migraine and its treatment

  2019cites this paper
• The role of the brainstem in migraine: Potential brainstem effects of CGRP and CGRP receptor activation in animal models

  2019influential citation
• CGRP/CGRP Receptor Antibodies: Potential Adverse Effects Due to Blockade of Neovascularization?

  2019cites this paper
• Calcitonin Gene‐Related Peptide Modulators – The History and Renaissance of a New Migraine Drug Class

  2019cites this paper
• CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice

  2019cites this paper
• Targeting calcitonin gene-related peptide: a new era in migraine therapy.

  2019cites this paper
• C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system

  2019influential citation
• Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing

  2018cites this paper
• Current understanding of trigeminal ganglion structure and function in headache

  2018cites this paper
• CGRP in Human Models of Migraine.

  2018cites this paper
• Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy

  2018cites this paper
• The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system

  2018cites this paper
• CGRP as the target of new migraine therapies — successful translation from bench to clinic

  2018cites this paper
• The CGRP Pathway in Migraine as a Viable Target for Therapies

  2018influential citation
• CGRP, Amylin, Immunology, and Headache Medicine

  2018cites this paper
• Effect of the H1-antihistamine clemastine on PACAP38 induced migraine

  2018cites this paper
• CGRP als therapeutisches Ziel in der Therapie von primären Kopfschmerzen

  2017cites this paper
• The role of calcitonin gene–related peptide in peripheral and central pain mechanisms including migraine

  2017influential citation
• Headache 2 The pathophysiology of migraine : implications for clinical management

  2017cites this paper
• The CGRP receptor antagonist BIBN4096 inhibits prolonged meningeal afferent activation evoked by brief local K+ stimulation but not cortical spreading depression-induced afferent sensitization

  2017cites this paper
• The pathophysiology of migraine: implications for clinical management.

  2017cites this paper
• CGRP and its receptors

  2017cites this paper
• CGRP Monoclonal Antibodies for Migraine: Rationale and Progress

  2017cites this paper
• The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine

  2017influential citation
• Pro-nociceptive migraine mediator CGRP provides neuroprotection of sensory, cortical and cerebellar neurons via multi-kinase signaling

  2017cites this paper
• Wiping Out CGRP: Potential Cardiovascular Risks.

  2016cites this paper
• Neue Therapieoptionen bei Migräne

  2016influential citation
• TIPS 1346 No . of Pages 10 Review Wiping Out CGRP : Potential Cardiovascular Risks

  2016cites this paper
• Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies.

  2016cites this paper
• Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.

  2016cites this paper
• The Journey to Establish CGRP as a Migraine Target: A Retrospective View

  2015cites this paper
• CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment.

  2015cites this paper
• Drugs Against Calcitonin Gene-Related Peptide and its Receptor Used in the Treatment of Migraine: What are the New Progresses?

  2015cites this paper
• Bedeutung des Neuropeptids CGRP bei primären Kopfschmerzen CGRP-Antikörper zur Migräneprophylaxe

  year unknowncites this paper